KR860000800A - 용해 유체내의 유효성분을 영차 방출하는 시방정 및 이의 제조방법 - Google Patents
용해 유체내의 유효성분을 영차 방출하는 시방정 및 이의 제조방법 Download PDFInfo
- Publication number
- KR860000800A KR860000800A KR1019850005159A KR850005159A KR860000800A KR 860000800 A KR860000800 A KR 860000800A KR 1019850005159 A KR1019850005159 A KR 1019850005159A KR 850005159 A KR850005159 A KR 850005159A KR 860000800 A KR860000800 A KR 860000800A
- Authority
- KR
- South Korea
- Prior art keywords
- sustained
- release tablet
- tablet according
- fluid
- active ingredient
- Prior art date
Links
- 239000012530 fluid Substances 0.000 title claims 11
- 239000004480 active ingredient Substances 0.000 title claims 8
- 238000002360 preparation method Methods 0.000 title 1
- 239000007939 sustained release tablet Substances 0.000 claims description 16
- 238000004090 dissolution Methods 0.000 claims 6
- 239000000654 additive Substances 0.000 claims 5
- 230000000996 additive effect Effects 0.000 claims 5
- 239000011248 coating agent Substances 0.000 claims 5
- 238000000576 coating method Methods 0.000 claims 5
- 239000000758 substrate Substances 0.000 claims 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 3
- 239000001913 cellulose Substances 0.000 claims 3
- 229920002678 cellulose Polymers 0.000 claims 3
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims 3
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims 3
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims 3
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims 3
- 239000001856 Ethyl cellulose Substances 0.000 claims 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims 2
- 229920002301 cellulose acetate Polymers 0.000 claims 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims 2
- 229920001249 ethyl cellulose Polymers 0.000 claims 2
- 235000019325 ethyl cellulose Nutrition 0.000 claims 2
- 239000000463 material Substances 0.000 claims 2
- 229920000642 polymer Polymers 0.000 claims 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical group OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 1
- 229930195725 Mannitol Natural products 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 229920006243 acrylic copolymer Polymers 0.000 claims 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims 1
- 239000008121 dextrose Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 239000000594 mannitol Substances 0.000 claims 1
- 235000010355 mannitol Nutrition 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000012466 permeate Substances 0.000 claims 1
- 239000004014 plasticizer Substances 0.000 claims 1
- 229920000058 polyacrylate Polymers 0.000 claims 1
- 229920006254 polymer film Polymers 0.000 claims 1
- 239000002861 polymer material Substances 0.000 claims 1
- 229920000193 polymethacrylate Polymers 0.000 claims 1
- 229920005862 polyol Polymers 0.000 claims 1
- 150000003077 polyols Chemical class 0.000 claims 1
- 239000011148 porous material Substances 0.000 claims 1
- 235000019260 propionic acid Nutrition 0.000 claims 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 238000013268 sustained release Methods 0.000 claims 1
- 239000012730 sustained-release form Substances 0.000 claims 1
- 229920006163 vinyl copolymer Polymers 0.000 claims 1
- 229920002554 vinyl polymer Polymers 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- External Artificial Organs (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Silver Salt Photography Or Processing Solution Therefor (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Feeding, Discharge, Calcimining, Fusing, And Gas-Generation Devices (AREA)
- Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
- Lubricants (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도와 제2도는 본 발명의 두 서방정을 구체적으로 표시한 종단면도.
Claims (16)
- (a)(i)용해 유체에 불용해성이고 불팽창성을 갖는 군질의 중합 물질로된 고체 다공성기질; (ii)용해 유체에서 용해하고 상기 유체에서 용해 부열을 갖는 첨가제; (iii)생물학적 유효성분으로 이루어지고, 상기 첨가제와 생물학적 유효성분이 상기 기질의 소공에 위치하는 저장기; (b) 상기 지장기상에 상기용해 유체에서 불용인 필름형성 중합체를 균일 및 연속적으로 피복시켜서 된 첫째 피막으로, 상기 유체와 이 유체에 용해된 상기 유효성분 용액이 투과할 수 있고, 이 첫째 피막의 두께가 다음 방정식으로 산출되는 첫째피막;(상기식에서 D는 상기 피막을 통하여 확산하는 상수이고; S는 상기 첫째 피막의 표면적을 나타내고; CS는 용해 유체내의 유효성분의 포화 상수이며; R은 방출속도이다)(c) 상기 첫째 피막위에 위치한, 용해 유체에 용해할 수 있는 필름-형성 중합물질의 균질 및 연속된 둘째 피막으로 이루어짐을 특징으로 하는, 용해 유체의 존재하에 장기간동안 일정한 속도로 생물학적 유효성분을 방출하는 서방정.
- 제1항에 있어서, 상기 저장기가 완충제를 함유함을 특징으로 하는 서방정.
- 제2항에 있어서, 상기 완충제가 상기 기질의 약 30중량%까지로 이루어짐을 특징으로 하는 서방정.
- 제1항에 있어서, 상기 생물학적 유효성분이 상기 저장기중 약 30-90중량%의 양으로 존재함을 특징으로 하는 서방정.
- 제1항에 있어서, 용해 부열을 갖는 용해 유체에 용해할 수 있는 상기 첨가제가 상기 저장기중 약 5-50중량%의 양으로 존재함을 특징으로 하는 서방정.
- 제5항에 있어서, 상기 첨가제가 폴리올 또는 산임을 특징으로 하는 서방정.
- 제6항에 있어서, 상기 첨가제가 마니톨, 덱스트로즈, 솔비틀 또는 킬리틀임을 특징으로 하는 서방정.
- 제1항에 있어서, 상기 기질이 상기 저장기중 약 3-20%로 이루어짐을 특징으로 하는 서방정.
- 제8항 에 있어서, 상기 기질의 중합 물질이 초산 셀룰로오즈, 고점도의 히드록시프로필 메틸셀루로오즈, 초산 프로피온산 세루로오즈, 에틸 셀루로오즈 또는 폴리메타크릴 레이트임을 특징으로 하는 서방정.
- 제1항에 있어서, 균일하고 연속된 상기 첫째 피막이 비닐 중합체 또는 공중합체, 셀루로오즈, 초산 셀루로오즈, 히드록시프로필메틸 샐루로오즈, 초산 프로피온산 셀루로오즈, 에틸 셀루로오즈, 아크릴 중합체 또는 아크릴 공중합체임을 특징으로 하는 서방정.
- 제1항에 있어서, 상기 둘째 피막이 저점도의 히드록시프로필메틸 셀루로오즈임을 특징으로 하는 서방정.
- 제1항에 있어서, 부가적 유효성분이 상기 둘째 중합체 피막에 존재함을 특징으로 하는 서방정.
- 제1항에 있어서, 가소제가 상기 첫째 피막에 존재함을 특징으로 하는 서방정.
- 제1항에 있어서, 상기 생물학적 유효성분이 경구 투약할 수 있는 약제임을 특징으로 하는 서방정.
- 제14항에 있어서, 상기 저장기의 외면이 두 대향된 구면대의 원형교차에 의하여 이루어진 양블록 원반상이고, 이 원반상의 직경이 6-16mm이고, 양블록 원반상의 구면대 휨 반경이 10-18mm이고, 양블록 원반상의 직경:두께 비율이 2-5임을 특징으로 하는 서방정.
- 제14항에 있어서, 상기 저장기가 중간 원통형 벽면대와 이 원통형 벽면대와 교차한 두 대향된 말단 구면대로 이루짐을 특징으로 하는 서방정.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT8448632A IT1206166B (it) | 1984-07-26 | 1984-07-26 | Dispositivo per rilasciare una sostanza in un fluido di dissoluzione con cinetica di ordine zero e procedimento per la sua preparazione |
IT48632A | 1984-07-26 | ||
IT48632A/84 | 1984-07-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR860000800A true KR860000800A (ko) | 1986-02-20 |
KR920005808B1 KR920005808B1 (ko) | 1992-07-20 |
Family
ID=11267748
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019850005159A KR920005808B1 (ko) | 1984-07-26 | 1985-07-19 | 용해 유체내의 유효성분을 영차 방출하는 서방정 및 이의 제조방법 |
Country Status (23)
Country | Link |
---|---|
US (1) | US4681755A (ko) |
EP (1) | EP0169821B1 (ko) |
JP (1) | JPS6143109A (ko) |
KR (1) | KR920005808B1 (ko) |
AT (1) | ATE60709T1 (ko) |
AU (1) | AU578299B2 (ko) |
BR (1) | BR8503539A (ko) |
DE (1) | DE3581673D1 (ko) |
DK (1) | DK166992B1 (ko) |
ES (1) | ES8801123A1 (ko) |
FI (1) | FI86372C (ko) |
GR (1) | GR851844B (ko) |
IE (1) | IE58120B1 (ko) |
IL (1) | IL75915A (ko) |
IN (1) | IN162047B (ko) |
IT (1) | IT1206166B (ko) |
MX (1) | MX173488B (ko) |
NO (1) | NO171004C (ko) |
PH (1) | PH22507A (ko) |
PT (1) | PT80865B (ko) |
TR (1) | TR23019A (ko) |
YU (1) | YU46156B (ko) |
ZA (1) | ZA855553B (ko) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3686275T2 (de) * | 1985-01-11 | 1993-03-18 | Teijin Ltd | Praeparate mit verzoegerter freisetzung. |
DE3505433A1 (de) * | 1985-02-16 | 1986-08-21 | Basf Ag, 6700 Ludwigshafen | Direkttablettierhilfsmittel |
SE450087B (sv) * | 1985-10-11 | 1987-06-09 | Haessle Ab | Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial |
SE455836B (sv) * | 1985-10-11 | 1988-08-15 | Haessle Ab | Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning |
US4898733A (en) * | 1985-11-04 | 1990-02-06 | International Minerals & Chemical Corp. | Layered, compression molded device for the sustained release of a beneficial agent |
US4775536A (en) * | 1986-02-24 | 1988-10-04 | Bristol-Myers Company | Enteric coated tablet and process for making |
US4891223A (en) * | 1987-09-03 | 1990-01-02 | Air Products And Chemicals, Inc. | Controlled release delivery coating formulation for bioactive substances |
SE8703881D0 (sv) * | 1987-10-08 | 1987-10-08 | Haessle Ab | New pharmaceutical preparation |
US5219621A (en) * | 1987-10-16 | 1993-06-15 | Elan Corporation, Plc | Methods of treatment with diltiazem formulations |
IL88083A (en) * | 1987-11-06 | 1992-11-15 | Tanabe Seiyaku Co | Controlled release pharmaceutical dosage form and its preparation |
US4859470A (en) * | 1988-06-02 | 1989-08-22 | Alza Corporation | Dosage form for delivering diltiazem |
US4931287A (en) * | 1988-06-14 | 1990-06-05 | University Of Utah | Heterogeneous interpenetrating polymer networks for the controlled release of drugs |
GR1000503B (el) * | 1988-12-07 | 1992-07-30 | Ferring Bv | Μεθοδος και συσκευη χρησιμη για την παροχη ιατρικων συνθεσεων στην κυστη και στην ουροποιητικη οδο. |
FR2640876B1 (ko) * | 1988-12-28 | 1993-09-24 | Jouveinal Sa | |
US4983399A (en) * | 1989-10-18 | 1991-01-08 | Eastman Kodak Company | Direct compression carrier composition |
US5378475A (en) * | 1991-02-21 | 1995-01-03 | University Of Kentucky Research Foundation | Sustained release drug delivery devices |
US5407686A (en) * | 1991-11-27 | 1995-04-18 | Sidmak Laboratories, Inc. | Sustained release composition for oral administration of active ingredient |
US20030170290A1 (en) * | 1993-06-16 | 2003-09-11 | Shug Austin L. | Delayed release carnitine |
WO1995005168A1 (en) * | 1993-08-19 | 1995-02-23 | Shug Austin L | Delayed release carnitine |
US5783212A (en) * | 1996-02-02 | 1998-07-21 | Temple University--of the Commonwealth System of Higher Education | Controlled release drug delivery system |
US5902598A (en) * | 1997-08-28 | 1999-05-11 | Control Delivery Systems, Inc. | Sustained release drug delivery devices |
US6342611B1 (en) * | 1997-10-10 | 2002-01-29 | Cytovia, Inc. | Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for capsases and other enzymes and the use thereof |
US6337091B1 (en) | 1997-10-27 | 2002-01-08 | Temple University - Of The Commonwealth System Of Higher Education | Matrix for controlled delivery of highly soluble pharmaceutical agents |
FR2772615B1 (fr) | 1997-12-23 | 2002-06-14 | Lipha | Comprime multicouche pour la liberation instantanee puis prolongee de substances actives |
SA99191255B1 (ar) | 1998-11-30 | 2006-11-25 | جي دي سيرل اند كو | مركبات سيليكوكسيب celecoxib |
US20040121014A1 (en) * | 1999-03-22 | 2004-06-24 | Control Delivery Systems, Inc. | Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
US6217895B1 (en) * | 1999-03-22 | 2001-04-17 | Control Delivery Systems | Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
US6375972B1 (en) | 2000-04-26 | 2002-04-23 | Control Delivery Systems, Inc. | Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
US20060159743A1 (en) * | 2001-10-25 | 2006-07-20 | Depomed, Inc. | Methods of treating non-nociceptive pain states with gastric retentive gabapentin |
ITMI20012481A1 (it) | 2001-11-23 | 2003-05-23 | Univ Parma | Sistemi modulari per il rilascio controllato di sostanza a controllo spaziale e temporale |
US8871241B2 (en) | 2002-05-07 | 2014-10-28 | Psivida Us, Inc. | Injectable sustained release delivery devices |
JP2005533101A (ja) * | 2002-07-10 | 2005-11-04 | ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー | アロステリック阻害剤又はマトリックス金属タンパク質分解酵素−13の、セレコキシブでもバルデコキシブでもないシクロオキシゲナーゼ−2の選択的阻害剤との組合せ物 |
US6986901B2 (en) * | 2002-07-15 | 2006-01-17 | Warner-Lambert Company Llc | Gastrointestinal compositions |
US20040010035A1 (en) * | 2002-07-15 | 2004-01-15 | Ciociola Arthur A. | Gastrointestinal compositions |
US7063862B2 (en) * | 2003-06-03 | 2006-06-20 | Biokey, Inc. | Pharmaceutical composition and method for treating |
US20060024368A1 (en) * | 2004-07-30 | 2006-02-02 | Reza Fassihi | Compressed composite delivery system for release-rate modulation of bioactives |
US8128460B2 (en) * | 2006-09-14 | 2012-03-06 | The Material Works, Ltd. | Method of producing rust inhibitive sheet metal through scale removal with a slurry blasting descaling cell |
CN101863942B (zh) * | 2009-04-14 | 2013-05-22 | 北京赛而生物药业有限公司 | 一种异丙肌苷的制备方法及其口服制剂 |
EP2515864A4 (en) * | 2009-12-23 | 2013-09-11 | Psivida Inc | DELAYED RELEASE DELIVERY DEVICES |
JP4877538B2 (ja) * | 2010-06-08 | 2012-02-15 | 東洋製罐株式会社 | シームレス缶体 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3275519A (en) * | 1965-10-01 | 1966-09-27 | Jacob A Glassman | Peroral pellet and the method of making same |
US3577512A (en) * | 1968-10-11 | 1971-05-04 | Nat Patent Dev Corp | Sustained release tablets |
US3832252A (en) * | 1970-09-29 | 1974-08-27 | T Higuchi | Method of making a drug-delivery device |
US4118336A (en) * | 1974-03-25 | 1978-10-03 | Toyo Jozo Company, Ltd. | Novel cellulose microcapsules and preparation thereof |
US4140756A (en) * | 1976-06-10 | 1979-02-20 | Mead Johnson & Company | Film-coated matrix core tablet |
US4180560A (en) * | 1976-10-26 | 1979-12-25 | Syntex Corporation | Inert core implant pellet |
US4218433A (en) * | 1977-03-03 | 1980-08-19 | Nippon Kayaku Kabushiki Kaisha | Constant-rate eluting tablet and method of producing same |
US4173626A (en) * | 1978-12-11 | 1979-11-06 | Merck & Co., Inc. | Sustained release indomethacin |
US4309405A (en) * | 1979-08-09 | 1982-01-05 | American Home Products Corporation | Sustained release pharmaceutical compositions |
FR2471186A1 (fr) * | 1979-12-10 | 1981-06-19 | Roussel Uclaf | Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation |
DE3013059A1 (de) * | 1980-04-03 | 1981-10-08 | Sandoz-Patent-GmbH, 7850 Lörrach | Neue galenische zusammensetzung |
JPS5835110A (ja) * | 1981-08-28 | 1983-03-01 | Tetsuo Kato | 徐放性マイクロカプセル |
IT1153487B (it) * | 1982-04-15 | 1987-01-14 | Prophin Lab Spa | Prodotti farmaceutici in forma-ritardo e procedimento per ottenerli |
US4557925A (en) * | 1982-07-08 | 1985-12-10 | Ab Ferrosan | Membrane-coated sustained-release tablets and method |
US4505890A (en) * | 1983-06-30 | 1985-03-19 | E. R. Squibb & Sons, Inc. | Controlled release formulation and method |
US4539198A (en) * | 1983-07-07 | 1985-09-03 | Rowell Laboratories, Inc. | Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion: expanded range |
-
1984
- 1984-07-26 IT IT8448632A patent/IT1206166B/it active
-
1985
- 1985-07-16 AT AT85830182T patent/ATE60709T1/de not_active IP Right Cessation
- 1985-07-16 DE DE8585830182T patent/DE3581673D1/de not_active Expired - Fee Related
- 1985-07-16 EP EP85830182A patent/EP0169821B1/en not_active Expired - Lifetime
- 1985-07-17 IE IE179685A patent/IE58120B1/en not_active IP Right Cessation
- 1985-07-18 IN IN555/MAS/85A patent/IN162047B/en unknown
- 1985-07-19 KR KR1019850005159A patent/KR920005808B1/ko not_active IP Right Cessation
- 1985-07-22 US US06/757,601 patent/US4681755A/en not_active Expired - Fee Related
- 1985-07-23 AU AU45251/85A patent/AU578299B2/en not_active Ceased
- 1985-07-23 ZA ZA855553A patent/ZA855553B/xx unknown
- 1985-07-24 JP JP60163777A patent/JPS6143109A/ja active Pending
- 1985-07-24 YU YU121485A patent/YU46156B/sh unknown
- 1985-07-24 TR TR33231/85A patent/TR23019A/xx unknown
- 1985-07-24 ES ES545679A patent/ES8801123A1/es not_active Expired
- 1985-07-25 NO NO852966A patent/NO171004C/no unknown
- 1985-07-25 IL IL75915A patent/IL75915A/xx not_active IP Right Cessation
- 1985-07-25 PH PH32566A patent/PH22507A/en unknown
- 1985-07-25 PT PT80865A patent/PT80865B/pt unknown
- 1985-07-25 FI FI852894A patent/FI86372C/fi not_active IP Right Cessation
- 1985-07-25 BR BR8503539A patent/BR8503539A/pt not_active IP Right Cessation
- 1985-07-25 DK DK339385A patent/DK166992B1/da not_active IP Right Cessation
- 1985-07-25 GR GR851844A patent/GR851844B/el unknown
- 1985-07-25 MX MX206098A patent/MX173488B/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR860000800A (ko) | 용해 유체내의 유효성분을 영차 방출하는 시방정 및 이의 제조방법 | |
JP2701977B2 (ja) | 疎水性媒体を含有する投薬体 | |
US4483846A (en) | Long-lasting three-layered pharmaceutical film preparations | |
KR100382901B1 (ko) | 활성성분의조절방출을위한장치 | |
US4886668A (en) | Multiparticulate controlled porosity osmotic pump | |
CA1317550C (en) | Dosage form for treating cardiovascular diseases | |
US4609374A (en) | Osmotic device comprising means for governing initial time of agent release therefrom | |
KR860002271A (ko) | 조절되게 방출되게끔(controlled-release) 코오팅된 조제학상의 제제와 그 제제의 제조방법 | |
Rippie et al. | Regulation of dissolution rate by pellet geometry | |
KR910011242A (ko) | 서방성 약학제제 및 그의 제조방법 | |
KR920002135A (ko) | 대장에서만 방출할수 있는 피복시킨 고체 약물형태 | |
KR840006765A (ko) | 지속성 방출 고형 제형의 제조방법 | |
JPS61103820A (ja) | 結腸一治療系 | |
JPS6058724B2 (ja) | 浸透性投薬器 | |
ES551505A0 (es) | Un sistema osmotico lipidico para dispersar agentes farmacologicamente activos. | |
EP0281708A2 (en) | A lamina composition and osmotic device containing the same | |
KR930003906A (ko) | 약학적 구상 제형 | |
KR880010759A (ko) | 방출 조절성 제제 | |
US4950486A (en) | Dosage form for treating cardiovascular diseases | |
US4946687A (en) | Dosage form for treating cardiovascular diseases | |
JPH0764725B2 (ja) | 徐放性錠剤およびその製造方法 | |
KR910018019A (ko) | 니트로글리세린의 경피 투여형 약제 | |
CA1320885C (en) | Controlled porosity osmotic pump | |
ZA200500834B (en) | Oral dosage form comprising a liquid active agent formulation and controlling release thereof by an expandable osmotic composition | |
ATE303796T1 (de) | Einzeldosisform zur verzögerten freisetzung mit einem latexüberzug sowie verfahren zu deren herstellung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
LAPS | Lapse due to unpaid annual fee |